Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1992 1
1998 1
2005 1
2006 1
2009 1
2010 2
2011 1
2012 1
2013 3
2014 5
2015 1
2016 3
2017 4
2018 2
2019 6
2020 3
2021 6
2022 1
2023 3
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Yu ping feng san for pediatric allergic rhinitis: A systematic review and meta-analysis of randomized controlled trials.
Liao Y, Zhong J, Liu S, Dai M, Liu Y, Li X, Yang Y, Zhang D, Lai D, Lu T, Zhang Q, Zhao Y. Liao Y, et al. Medicine (Baltimore). 2021 Apr 2;100(13):e24534. doi: 10.1097/MD.0000000000024534. Medicine (Baltimore). 2021. PMID: 33787571 Free PMC article.
BACKGROUND: The potential treatment effects and safety of Yu ping feng san (YPFS) for pediatric allergic rhinitis (PAR) patients have yet to be studied systematically. ...
BACKGROUND: The potential treatment effects and safety of Yu ping feng san (YPFS) for pediatric allergic rhiniti …
Yu-Ping-Feng-San alleviates inflammation in atopic dermatitis mice by TLR4/MyD88/NF-kappaB pathway.
Nie J, Jiang X, Wang G, Xu Y, Pan R, Yu W, Li Y, Wang J. Nie J, et al. J Ethnopharmacol. 2024 Jul 15;329:118092. doi: 10.1016/j.jep.2024.118092. Epub 2024 Apr 9. J Ethnopharmacol. 2024. PMID: 38604509
ETHNOPHARMACOLOGICAL RELEVANCE: Yu-Ping-Feng-San (YPF) is a traditional Chinese medicine formula that has therapeutic effects on allergic diseases such as allergic rhinitis and asthma. ...
ETHNOPHARMACOLOGICAL RELEVANCE: Yu-Ping-Feng-San (YPF) is a traditional Chinese medicine formula that has therap …
Effects of Yu-Ping-Feng polysaccharides on animal growth performance and immune function: a review.
Chu H, Zong Y, Yang H, Chen S, Ma Z, Li H. Chu H, et al. Front Vet Sci. 2023 Sep 20;10:1260208. doi: 10.3389/fvets.2023.1260208. eCollection 2023. Front Vet Sci. 2023. PMID: 37799408 Free PMC article. Review.
Yu-Ping-Feng polysaccharides (YPF-P) is the primary component of Yu-Ping-Feng San (YPF-S) medicine prescription, which consists of three polysaccharides from Astragalus Membranaceus polysaccharide (AM-P), Atractylodes Macrocephala polysaccharide (AM-P) …
Yu-Ping-Feng polysaccharides (YPF-P) is the primary component of Yu-Ping-Feng San (YPF-S) medicine prescription, …
Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma.
Xue L, Li C, Ge G, Zhang S, Tian L, Wang Y, Zhang H, Ma Z, Lu Z. Xue L, et al. Front Pharmacol. 2021 Jul 9;12:703724. doi: 10.3389/fphar.2021.703724. eCollection 2021. Front Pharmacol. 2021. PMID: 34305612 Free PMC article.
Group 2 innate lymphoid cells (ILC2s) are an important source of type 2 cytokines IL-5 and IL-13, which contribute to the progress of asthma. Jia-Wei-Yu-Ping-Feng-San (JWYPFS), a traditional Chinese medicine, has been widely used to treat asthma in Chi …
Group 2 innate lymphoid cells (ILC2s) are an important source of type 2 cytokines IL-5 and IL-13, which contribute to the progress of asthma …
Potential effectiveness of Chinese herbal medicine Yu ping feng san for adult allergic rhinitis: a systematic review and meta-analysis of randomized controlled trials.
Luo Q, Zhang CS, Yang L, Zhang AL, Guo X, Xue CC, Lu C. Luo Q, et al. BMC Complement Altern Med. 2017 Nov 6;17(1):485. doi: 10.1186/s12906-017-1988-5. BMC Complement Altern Med. 2017. PMID: 29110710 Free PMC article. Review.
BACKGROUND: Chinese herbal medicine formula Yu ping feng san (YPFS) is commonly used for allergic rhinitis (AR). Previous review had summarized the effectiveness and safety of YPFS, however without any subgroup analysis performed to provide detailed ev …
BACKGROUND: Chinese herbal medicine formula Yu ping feng san (YPFS) is commonly used for allergic rhinitis (AR). …
Chinese medicine Yu-Ping-Feng-San attenuates allergic inflammation by regulating epithelial derived pro-allergic cytokines.
Wang XT, Liu HL, Yu X, Wang C, Gui LL, Wang XY, Hua YQ, Zheng J, Hong M. Wang XT, et al. Chin J Nat Med. 2019 Jul;17(7):525-534. doi: 10.1016/S1875-5364(19)30074-3. Chin J Nat Med. 2019. PMID: 31514984
This study aimed to investigate the mechanisms of Yu-Ping-Feng-San (YPFS) on attenuating allergic inflammation in the initial stage of atopic dermatitis (AD). ...
This study aimed to investigate the mechanisms of Yu-Ping-Feng-San (YPFS) on attenuating allergic inflammation i …
Yu-Ping-Feng-San ameliorates recurrent allergic inflammation of atopic dermatitis by repairing tight junction defects of the epithelial barrier.
Zheng J, Wang X, Tao Y, Wang Y, Yu X, Liu H, Ji L, Bao K, Wang C, Jia Z, Hong M. Zheng J, et al. Phytomedicine. 2019 Feb 15;54:214-223. doi: 10.1016/j.phymed.2018.09.190. Epub 2018 Sep 19. Phytomedicine. 2019. PMID: 30668371
BACKGROUND: Atopic dermatitis (AD) is a common allergic inflammatory skin disease, concomitant with a high relapse rate. Yu-Ping-Feng-San (YPFS), a well-known Chinese herbal decoction, reduces the AD relapse rate and recurring severity incidence. ...
BACKGROUND: Atopic dermatitis (AD) is a common allergic inflammatory skin disease, concomitant with a high relapse rate. Yu-Ping …
The Mechanisms of Yu Ping Feng San in Tracking the Cisplatin-Resistance by Regulating ATP-Binding Cassette Transporter and Glutathione S-Transferase in Lung Cancer Cells.
Du Y, Zheng Y, Yu CX, Zhong L, Li Y, Wu B, Hu W, Zhu EW, Xie VW, Xu Q, Zhan X, Huang Y, Zeng L, Zhang Z, Liu X, Yin J, Zha G, Chan K, Tsim KWK. Du Y, et al. Front Pharmacol. 2021 May 28;12:678126. doi: 10.3389/fphar.2021.678126. eCollection 2021. Front Pharmacol. 2021. PMID: 34135758 Free PMC article.
Cisplatin is one of the first line anti-cancer drugs prescribed for treatment of solid tumors; however, the chemotherapeutic drug resistance is still a major obstacle of cisplatin in treating cancers. Yu Ping Feng San (YPFS), a well-known ancient Chine …
Cisplatin is one of the first line anti-cancer drugs prescribed for treatment of solid tumors; however, the chemotherapeutic drug resistance …
Yu Ping Feng San Exert Anti-Angiogenesis Effects through the Inhibition of TSLP-STAT3 Signaling Pathways in Hepatocellular Carcinoma.
Yuan Q, Yao F, Zhou L, Liang G, Song X, Jiang G, Zhou M, Zhang L. Yuan Q, et al. Evid Based Complement Alternat Med. 2019 Oct 23;2019:1947156. doi: 10.1155/2019/1947156. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31885639 Free PMC article.
BACKGROUND: Clinically, Yu ping feng san (YPFS) has been extensively used as a medication for treating immune deficiency, and YPFS is combined with chemotherapy drugs to treat cancer, including hepatocellular carcinoma (HCC), lung cancer, and pancreati …
BACKGROUND: Clinically, Yu ping feng san (YPFS) has been extensively used as a medication for treating immune de …
44 results